Is Intimal Hyperplasia Associated with Cranial Arterial Stenosis in Cannabis-Associated Cerebral Infarction?

Bachs L. Morland H. Acute cardiovascular fatalities following cannabis use. Forensic Sci Int 2001; 124:200–3.

Jouanjus E. Leymarie F. Tubery M. Lapeyre-Mestrel M. Cannabis-related hospitalizations: Unexpected serious events identified through hospital databases. Br J Clin Pharmacol 2011; 71:758–65.

Mehmedic Z. Chandra S. Slade D. . Potency trends of Δ9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008. J Forensic Sci 2010; 55:1209–17.

Arnold C. The potency of THC in cannabis products. Working Paper Series No.1. National Advisory Committee on Drugs, Dublin, 2011. Available at http://www.drugs.ie/resourcesfiles/research/2011/thc_cannabis.pdf (accessed 23 November 2013).

Desbois A.C. Cacoub P. France P. Cannabis-associated arterial disease. Ann Vasc Surg 2013; 27:996–1005.

Wolff V. Armspach J-P Lauer V. . Cannabis-related stroke myth or reality? Stroke 2013; 44:558–63.

Disdier P. Granel B. Serratrice J. . Cannabis arteritis revisited ten new case reports. Angiology 2001; 52:1–5.

Makkuni1 D. Bharadwaj A. Wolfe K. Payne S. Hutchings A. Dasgupta B. Is intimal hyperplasia a marker of neuroophthalmic complications of giant cell arteritis? Rheumatology 2008; 47:488–90.

Kaiser M. Weyand C.M. Bjornsson J. Goronzy J.J. Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis. Arthritis Rheum 1998; 41:623–33.

Chen Y. Buck J. Cannabinoids protect cells from oxidative cell death: A receptor-independent mechanism. J Pharmacol Exp Ther 2000; 293:807–12.